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Erythema multiforme is an acute, self-limited, but frequently 
recurrent illness, characterized by an eruption that can involve 
both skin and mucous membranes [1]. The association of ery-
thema multiforme with administration of drugs and with an 
immune response to an infectious agent has led to the hypoth-
esis that the genesis of this syndrome involves the host immune 
response [2]. Although the nature of such an immune patho-
genesis is currently unknown, individual case studies have 
demonstrated complement abnormalities a~d circulating im-
mune complexes in patients with typical cutaneous lesions of 
erythema multiforme [3-5]. 
In order to evaluate a possible role for immune complexes in 
the pathogenesis of erythema multiforme, we have studied sera 
from 36 patients with active erythema multiforme for the 
presence of 2 markers of circulating immune complexes, cryoim-
one of the patients had a mild cutaneous disease, 6 ha d oral lesions as 
well as cutaneous lesions and 9 had severe mucous membrane involve-
ment, the Stevens-Johnson syndrome. Thirty-six healt hy volunteers, 
18 males a nd 18 females, ages 19 to 55 (mean age of 30.1 ) submitted 
blood samples which were studied in the same manner as t hose from 
the patients. 
Isolation of Cryoprecipitates 
Cryoprecipitates were isolated as previously described [6], usually 
from 50 ml blood samples. After incubation of the blood for 1 hr at 
37°C and removal of the clot and a ll cells, 1 ml aliquot of serum was 
frozen at -70°C for the 125I C1q binding studies, and the rest of the 
serum was refrigerated at 4 oc for 7 days. Cryoprecipitates were washed 
4 t imes with cold phosphate buffered saline (PBS), pH 7.2, and sus-
pended in 0.5 ml of 0.05 M barbital buffer, pH 8.2. T he solubility of the 
cryoprecipitates in this buffer, a lthough incomplete, was greater than 
TABLE I. Findings in patients with postherpetic erythema multifonne 
Age/ Sex Clinical features % '"'I Clq Binding 
Cryopr~tein C
ryoimmunoglobulins 
(mg/ 100 ml serum) Skin IF (mg/ 100 ml serum) 
22/M Cutaneous and oral 9.0 
17/ F CuLaneous 10.7 
26/M Cutaneous and oral 28.6 
29/M Cutaneous 10.1 
21/M Cutaneous 30.7 
24 / M Cutaneous 4.8 
24/M Cutaneous 9.1 
23/M Cutaneous and oral 5.9 
15/ M Cutaneous 13.1 
60/F Cutaneous 12.6 
32/M Cutaneous 7.6 
6/F Cutaneous 7.0 
munoglobulins and elevated 125IClq binding activity. A similar 
evaluation of sera from 36 control subjects was carried out. 
MATERIALS AND METHODS 
Patients 
Thirty-six patients, 21 men and 15 women, ages 6 to 77 with a mean 
age of 33.5, with typical skin lesions with or without mucosal lesions 
were studied at a t ime when skin lesions were still occurring. All 
pat ien ts had fixed erythematous papules which evolved in the round 
" iris" or "target" lesions a nd which were distributed symmetrically, 
usually grouped over extensor surfaces. In 12 patients, the erythema 
multiforme was postherpetic (Table 1), in 5, drug related (Table II) ; 
and in 2 mycoplasma related (Table III). In the other 17 cases, either 
no precipitating factors or unusual ones were found (Table III) . Twenty-
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PBS: phosphate buffered saline 
PEG: polyethylene glycol 
lgG IgA lgM 
0.0 0.00 0.00 0.00 ND 
3.5 0.22 0.06 0.38 ND 
0.0 0.00 0.00 0.00 Pos. 
0.0 0.00 0.00 0.00 Pos. 
5.0 0.83 0.17 2.58 Pus. 
0.0 0.00 0.00 0.00 ND 
0.0 0.00 0.00 0.00 ND 
1.1 0.19 0.00 0.27 ND 
1.2 0.00 0.00 0.25 ND 
0.9 0.00 0.00 0.17 ND 
2.2 0.18 0.05 0.20 ND 
3.3 1.15 0.00 0.96 Pos. 
in PBS. Cryoprecipitates and the supernatant sera were main tained 
frozen at -70°C until studied further. 
Characterization of Cryoprecipitates 
The protein content of each cryoprecipitate was dete rmined by the 
method of Bradford [7]. The amounts of IgG , lgM, lgA, and Ca in the 
cryoprecipi tates were quantitated by radial immunodiffusion on low 
level plates (Kallestad Laboratories, Chaska, Minnesota). T hese results 
were expressed as mg/ 100 ml of origina l serum. 
125/ Clq Binding Assay 
The 12"I Clq binding assay for immune complexes was perfo rmed by 
the met hod of Zubler [8]. C1q was isolated from normal human serum, 
radiola beled with 12''1, and reacted with the test sera. Separation of free 
from complex-bound m.I Clq was achieved by selective precipi tation 
with polyethy lene glycol (PEG) at a final concentration of 2.5%. T he 
radioactivi ty precipi tated by PEG was compared to that precipitated 
in a control tube by 20% trichloroacetic acid and was expressed as 
percentage 1251 C1q bound. Samples were tested in dup licate and '2''I 
C1q binding activi ty (Clq BA) was reported as the mean of the two 
determinations. Clq BA was measm ed in 36 healthy control subjects. 
Previous C1q BA from 100 healthy control subjects showed the mean 
binding and standard deviation (SD) of this group were 8.8% and 2.7% 
respectively. A Clq BA greater than 14.2% (mean+ 2 SD) was consid-
ered abnormal. 
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Shin Immunofluorescence 
Biopsies of erythema multiforme skin lesions including the erythe-
matous border, as suggested by Kazmierowski and Wuepper [9), were 
obtained from 13 of the erythema multiforme subjects (Tables I-III). 
The t issue was snap frozen in liquid nitrogen and sectioned at 4 J.Lm on 
Ames cryostat [10). Fluoroscein-labeled monovalent antisera to human 
IgG, lgM, lgA, C3 and fibrin (Bering Laboratories) were incubated with 
the frozen section and washed free of excess reagent. Sections were 
examined under a Zeiss fluore.;;cent microscope with a clarkfield con-
densor using a BG-12 primary filter and a gelatin W-12 secondary ftlter. 
Statistics 
The serum levels of cryoglobulins in patients and controls were 
compared by the student t-test. The presence of mixed cryoglobulins 
and elevated 1251 C1q binding activity were compared by the Chi-square 
or Fisher's exact test. 
RESULTS (Table II) 
Twenty-three of the 36 sera from erythema multiforme pa-
tients contained low levels of cryoprotein (Tables I-III). The 
mean value of cryoprecipitable protein in this group was 1.82 
mg per 100 ml serum (Table IV). Fourteen of the 36 control 
sera had low levels of cryoproteins. The mean for the group 
was 0.60 mg/ 100 ml serum. The erythema multiforme patients 
had significantly higher levels of cryoprotein (p < 0.01) than 
the controls. Similarly, erythema multiforme patients were 
more likely than controls to have mixed cryoglobulins, that is, 
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!ins (mg/100 ml serum) Skin IF 
IgG IgA IgM 
0.00 0.00 0.00 ND 
0.00 0.00 0.00 ND 
0.00 0.00 0.46 ND 
0.00 0.00 0.41 Pos. 
0.00 0.00 0.00 Neg. 
" Cases also associated with X-irradiation. 
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2 or more immunoglobulins in the cryoprecipitates (p = .003). 
Fifty percent of erythema multiforme patients studied had 
mixed cryoglobulinemia at the time they were having skin 
lesions, while only 11% of controls demonstrated this finding. 
The erythema multiforme patients were also significantly dif-
ferent in the presence of each of the three individual immuno-
globulins (p < .01). Sera from erythema multiforrne patients 
TABLE IV. 125I Clq binding activity and cryoprotein analyses, sera 




(N = 36) 
Control 
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'" I Clq 
IgG IgA I M 2 or binding g more Ig 
1.82 ± 0.32 15 14 22 18 7 
0.60 ± 0.16 4 2 10 4 2 
TABLE V. Immunofluorescent findings in biopsies from 13 patients 




















































Total number 4/13 1/13 3/13 7/ 13 3/13 3/13 5/13 4/ 13 
positive 
TABLE III. Findings in patients with erythema multifonne associated with mycoplasma infections or unllno_wn causes 
Cryoimmunoglobulins 
Age/Sex Clinical Features % '"'I Clq Binding Cryoprotein (mg/ 1 00 (mg/100 rnl serum) Skin IF rnl serum) 
IgG lgA IgM 
15/M" Stevens-Johnson syndrome 12.5 5.0 0.17 0.07 1.18 NO 
12/ M" Stevens-Johnson sym:U-ome 23.9 0.0 0.00 0.00 0.00 NO 
24/F Cutaneous and oral 6.0 0.0 0.00 0.00 0.00 ND 
14/M Cutaneous 21.1 1.0 0.00 0.06 0.10 ND 
26/F Cutaneous 17.4 2.1 0.25 0.09 0.39 ND 
30/ M Cutaneous 7.3 3.1 0.19 O.D7 1.63 NO 
56/F Stevens-J ohnson syndrome 6.2 0.0 0.00 0.00 0.00 ND 
77/ F Cutaneous 29.6 2.3 0.21 0.04 1.05 ND 
29/F Cutaneous and oral 10.7 3.0 0.18 0.08 1.18 Pos. 
23/M Cutaneous 6.3 2.3 0.09 0.00 0.10 ND 
74/ F Cutaneous 7.0 0.0 0.00 0.00 0.00 NO 
19/ M Cutaneous 10.8 7.7 0.63 0.17 1.40 ND 
67/ F Cutaneous 8.8 1.4 0.00 0.09 0.45 Pos. 
38/M Cutaneous 8.1 0.0 0.00 0.00 0.00 Neg. 
50/ M'' Cutaneous, oral, nasal 13.3 3.0 0.00 0.13 0.50 Pos. 
33/M Cutaneous 8.4 2.5 0.23 0.00 0.87 Pos. 
43/F Cutaneous 8.8 4.9 0.25 0.08 0.91 Pos. 
13/F Stevens-Johnson syndrome 12.2 0.0 0.00 0.00 0.00 NO 
57/M' Cutaneous 32.1 5.1 1.06 0.23 0.80 Pos. 
" Associated with mycoplasmal infections. 
1
' Associated with herpes zoster. 
,. Associated with streptococcal infection. 
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also had elevated 1251 C1q binding: 7 of 36 erythema multiforme 
sera had elevated C1q binding, compared to 2 of 36 controls (p 
= .08 by one-tailed Fisher's exact' test). 
Positive skin immunofluorescence was found in 11 of the 13 
erythema multiforme biopsies. Eight of the 11 demonstrated 
granular deposition of immunoglobulin or complement, either 
at the dermal-epidermal junction or around upper dermal blood 
vessels, while 3 were positive for fibrin only at the dermal-
epidermal junction (Table V). Specimens positive for immu-
noglobulin demonstrated lgM or lgG but not lgA. 
DISCUSSION 
He bra stated in 1866 that he had no knowledge of the genesis 
of the disease he called erythema multiforme exudativum [11]. 
Over a century later, understanding of the pathogenesis of 
erythema multiforme has not advanced far. Because no animal 
model has been identified, investigations into the pathogenesis 
of this disease have been slow. 
Present evidence suggests that immune mechanisms are in-
volved in the pathogenesis of erythema multiforme. The Hst of 
factors which precipitate erythema multiforme [2), primarily 
infections and drugs, are somewhat similar to Hsts of agents 
which precipitate other syndromes of immunological pathogen-
esis, such as glomerulonephritis and serum sickness [12]. The 
onset of erythema multiforme associated with infectious dis-
eases is temporally associated with positive skin tests and 
serologic evidence of immunity to the infectious agent [13, 14]. 
An occasional serum specimen from a patient with active ery-
thema multiforme has shown anticomplementary activity, a 
finding marking the presence of immune complexes [13, 15]. 
Depressed complement values and immune complexes have 
been reported in sera of individual patients with erythema 
multiforme [3-5), as well as the blister fluid of bullous erythema 
multiforme skin lesions [16). Direct immunofluorescent studies 
of skin lesions of erythema multiforme have demonstrated Ca 
or C3 plus lgM around the microvasculature of the papillary 
dermis, evidence compatible with vascular injury from immune 
complexes. 
This study demonstrates evidence supporting the presence of 
immune complexes in patients with erythema multiforme. In 
the sera of 20 of the 36 patients, either mixed cryoglobulins, 
elevated 1251 C1q binding or both were found. Patients with 
mild cutaneous forms of erythema multiforme were as likely to 
have these 2 markers of circulating immune complexes as those 
with the severe Stevens-Johnson syndrome. Fifty percent of 
erythema multiforme patients had mixed cryoglobulinemia. 
The vigorous washing procedure for isolating cryoimmunoglob-
ulins results in loss of contaminating protein but reduces the 
total recoverable protein. Patients, in this study had levels of 
cryoimmunoglobuHns approximately 10 to 20% of that reported 
in other cryoglobulinemic states [17) but still significantly 
higher than controls. We obtained 50 ml rather than 5 or 10 ml 
of blood which allowed detection of lower levels of cryoproteins. 
In our study we detected positive immunofluorescence for 
immunoglobuHns or complement in 8 of 13 patients, a frequency 
somewhat less than that reported by Kazmierowski and Wuep-
per [9]. Possibly, the lesions that we biopsied were older than 
those that they studied. Our finding of fibrin deposition in many 
of the specimens would suggest the presence of well developed 
inflammatory reactions. Positive findings in our specimens in-
cluded not only granular deposition of lgM or C3 around upper 
dermal blood vessels but also granular IgG around blood vessels 
and both lgG and Ca at the dermal epidermal junction. 
We believe that the presence of 1251 C1q binding, mixed 
cryoglobuHnemia and granular deposits of immune reactants 
around cutaneous blood vessels indicate that cii·culating im-
mune complexes are present in erythema multiforme and may 
be involved in the pathogenesis of the erythema multiforme 
syndrome. 
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PANEL DISCUSSION 
Humoral and Cellular Aspects in Erythema Multiforme 
MODERATOR: Kirk Wuepper, M.D. 
PANEL: Drs. Kirk Wuepper, Robert Jordon, and William Weston 
TuRK: Dr. Wuepper, When you put your list of condit ions down you 
mentioned erythema nodosum, but what we actually studied was ery-
thema nodosum leprosum which is a very different condition clinically, 
as well as histologically, because of its predominantly granulocytic 
inftltrate, whereas in erythema nodosum there is mainly a mononuclear 
cell infiltrate. Parish showed that immune complexes would deposit 
secondarily on damaged vascular endothelium in the skin. Could the 
immune complexes in erythema multiforme have deposited secondarily 
to T-cell-antigen interaction damaging vascular endothelium? Finally 
Cream, in 1971, in my laboratory at the Institute of Dermatology in 
London, studied cryoglobulin in "allergic vasculitis." He found circulat-
ing cryoglobulins only in chronic cases. Was there a greater incidence 
of cryoglobulins in chronic as opposed to acute cases in your study? 
WESTON: We detected the cryoglobulins during the earliest stage we 
could examine the patients which is often within the fu·st 48 hr of 
illness. The level of cryoglobulins detected in these studies was about 
20% of what one might get in a rheumatoid disease or as we have found 
in several patients with erythema nodosum leprosum so these are much 
lower levels than one ordinarily obtains. We have had the opportunity 
to study some of these patients during the more severe form of the 
disease and found that as late as 2 weeks or 3 weeks after the onset of 
the skin lesions, they still had cryoglobulins present. 
TURK: Were these recurrent cases with attacks over a period of years 
or were these patients who came up with one attack? 
WESTON: These were patients with the first attack. 
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WUEPPER: But one does see those cases that have recurrent herpes 
and erythema mult iforme, constantly cycling every week or two. Cer-
ta inly, that person might have constant immune complexes. I think 
that may be just the kind of individual that Dr. Wintroub reported, 
because he said that person had had some 50 episodes. In any event, 
that might account for the find ings in norma l skin. I appreciate your 
pathologic annotation d istinguishing E. nodosum leprosum from E. 
nodosum. I've seen 3 or 4 biopsies from erythema nodosum and found 
immune-reactants in arteriolar vesse ls deep in the dermis. Have others 
sha red that experience? 
TURK: I would like to go back to that fu·st question I asked. To what 
extent do you think that the deposition of immune complexes is 
secondary to damaged vascular endo thelium. 
WuEPPEH: My belief is that the complexes come first and the 
lymphocytes second but other people can just as fairly believe other-
wise. 
KATZ: Do you see Ig deposits in normal skin in EM patients as is 
seen in many patients with cutaneous vasculitis. 
W UEPPER: I did not in 5 instances. 
KATZ: Do you think the reason IgG deposits are not seen by direct 
IF is because of the high background? 
WUEPPER: I think the high background with lgG makes it the most 
difficult immunoglobulin for these kinds of studies. 
JORDON: I agree that IgG is the most difficult one, since this immu-
noglobulin is in the largest concentration and it is in the tissues itself. 
WUEPPEH: The amount of edema fluid that one has may enhance 
the background as well. 
GIGLI: Do you resolubilize your cryoprecipitate to exclude other 
proteins which may cryoprecipitate as well. 
WESTO N: The fibrinogen is washed free of the cryoimmunoglobulins. 
We did not actually detect any cryofibrinogens in any of the cases. 
WuEPPEH: In so many immune complex disorders, one is handi-
capped by not having any notion what the virus might be. In this 
herpes simplex model one at least would anticipate some antigens from 
the herpes virus to be participat ing in such a complex and Dr. Weston 
has published an abstract in which he, in fact, detected HSV antigens. 
WESTON: We reported in abstract form t he finding that some of 
these isola ted cryoproteins contained herpes antigen. The problem with 
the study, is that in re-evaluating the results we do not have a lo t of 
confidence in the specificity of the antisera. We are preparing new 
antisera and are trying to repeat all those studies, as well as prospec-
tively culturing herpes simplex virus from the mouth and skin lesions 
and trying to detect it in cryostat sections by fluorescent tagged 
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antibody. I think aU that work needs to be s tarted over again. 
WUEPPER: I have used a commercial antiherpes virus antiserum, 
which is probably made to the coat of the virus, in the study of 4 
patients by immunofluorescence, but I was unsuccessful in identifying 
antigens. 
SoTER: Is there a correlation between the presence of underlying 
cryoglobulins and cause, especia lly herpes virus, in patients with ery-
thema multiforme? 
WESTON : There really is no a direct correlation between an infectious 
association and those that have unknown association. 
LAWL EY: Is there any relationship between the level or presence of 
circulat ing immune complexes (CIC) and disease activity and the level 
or presence of CIC and the underlying disease? 
W uEPPER: I think that Dr. Lawley's point is one that we all have 
considered and some patients need to be studied longitudinally and 
frequently over a period of t ime to make more significant statements. 
JoRDON: We have 2 patients with herpes simplex virus associated 
erythema multiforme that we studied in that way. In one of them we 
actually detected complexes at a time when the disease seemed to be 
subsiding and I think that about 8 mo later during a severe episode we 
could not detect immune complexes. But we have seen different pat-
terns in different patients so that is not the rule. 
MANNIK: In the study of the cryoglobulins you ment ioned that by 
analyzing the concentration of immunoglobulins by radial immunodif-
fus ion you could not account for all the protein. At least in part this 
may result from the fact that radial immunodiffusion underestimates 
the content of immunoglobulins in complexes since in a complex only 
one molecule is recognized as a single antigen. Do you use fluoroscein-
ated F(ab')2 to avoid nonspecific binding to tissues when you look for 
immunoglobulins? 
WESTON: It depends on whether or not there are Fe receptors in the 
tissue that can nonspecifically bind. 
MANNIK: It is not only Fe receptors. lgG molecules are notorious for 
nonspecifically binding to many things and thus if there is any question, 
this would be a usable technique. The third comment is whether in 
erythema multiforme is there any evidence of immune complex disease, 
and in particular, any evidence of renal disease. Over the years we have 
learned from lupus that clinically only 50% of patients have evidence of 
renal disease, yet when those patients who have no clinical evidence or 
renal involvemennt had biopsies, all of them had abnormalities. 
WUEPI'ER: There are 3 reports of nephritis in association with 
erythema multiforme, or lung involvement or cerebritis in one form or 
another, but that is generally quite rare. 
